 Aprea Therapeutics APRE stock is seeing major gains on Wednesday after revealing results from a recent Phase 12 trial. The post APRE Stock: The Big Leukemia Study News That Has Aprea Therapeutics Skyrocketing Today appeared first on InvestorPlace. 